MDM2启动子单核苷酸多态性309T>G决定卒中后功能结局
研究探讨MDM2启动子SNP309通过调控p53介导的凋亡影响卒中后功能结局。体外和动物实验显示缺血诱导MDM2表达并与p53结合,干扰该结合或敲低MDM2导致p53积聚并增加神经元对氧糖剥夺所致凋亡的易感性。两个医院队列(缺血性卒中408例、脑出血128例)中,携带G等位基因者MDM2蛋白水平更高且功能结局优于T/T基因型,T/T基因型与缺血性卒中大面积梗死及脑出血较大病灶体积相关。
要点
- MDM2 SNP309的G等位基因携带者卒中后功能结局优于T/T基因型。
- T/T基因型与缺血性卒中大面积梗死及脑出血较大病灶体积相关。
- 干扰MDM2-p53结合或敲低MDM2可致p53积聚并增加神经元凋亡易感性。
核心结论
- MDM2-p53相互作用在缺血后神经元凋亡中起新作用,MDM2 SNP309决定卒中患者功能结局。
研究设计与样本
- 原代皮层神经元接受氧糖剥夺处理。
- 小鼠接受缺血性(短暂大脑中动脉闭塞)或出血性(胶原酶注射)卒中模型。
- 在神经元和脑提取物中检测MDM2和p53的蛋白及mRNA水平。
- 采用nutlin-3a干扰MDM2与p53结合,采用siRNA敲低MDM2表达。
- 分析两个独立医院卒中队列中MDM2 SNP309与改良Rankin量表评分所示功能结局的关联:缺血性卒中队列408例,脑出血队列128例。
主要发现
- 实验性卒中及氧糖剥夺分别诱导脑和神经元中MDM2表达。
- 氧糖剥夺促进神经元中MDM2与p53结合。
- nutlin-3a干扰MDM2-p53结合或siRNA敲低MDM2触发p53积聚,增加神经元对氧糖剥夺诱导凋亡的易感性。
- 携带MDM2启动子G等位基因的患者MDM2蛋白水平高于T/T基因型者,且卒中后功能结局优于T/T基因型者。
- T/T基因型与缺血性卒中大面积梗死体积及脑出血患者较大病灶体积相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- The E3 ubiquitin ligase MDM2 (murine double minute 2) is the main negative regulator of the p53 protein-a key player in neuronal apoptosis after ischemia. A functional single-nucleotide polymorphism in the human MDM2 gene promoter (rs2279744) regulates MDM2 protein expression. We investigated whether the MDM2 SNP309, by controlling p53-mediated apoptosis, determines functional outcome after stroke. Methods- Primary cortical neurons were subjected to oxygen and glucose deprivation. Mice were subjected to ischemic (transient middle cerebral artery occlusion) or hemorrhagic (collagenase injection) stroke models. Protein and mRNA levels of MDM2 and p53 were measured in both neuronal and brain extracts. The interaction of MDM2 with p53 was disrupted by neuronal treatment with nutlin-3a. siRNA was used to knockdown MDM2 expression. We analyzed the link between the MDM2 SNP309 and functional outcome, measured by the modified Rankin Scale scores, in 2 independent hospital-based stroke cohorts: ischemic stroke cohort (408 patients) and intracerebral hemorrhage cohort (128 patients). Results- Experimental stroke and oxygen and glucose deprivation induced the expression of MDM2 in the brain and neurons, respectively. Moreover, oxygen and glucose deprivation promoted MDM2 binding with p53 in neurons. Disruption of the MDM2-p53 interaction with nutlin-3a, or MDM2 knockdown by siRNA, triggered p53 accumulation, which increased neuronal susceptibility to oxygen and glucose deprivation-induced apoptosis. Finally, we showed that patients harboring the G allele in the MDM2 promoter had higher MDM2 protein levels and showed better functional outcome after stroke than those harboring the T/T genotype. The T/T genotype was also associated with large infarct volume in ischemic stroke and increased lesion volume in patients with intracerebral hemorrhage. Conclusions- Our results reveal a novel role for the MDM2-p53 interaction in neuronal apoptosis after ischemia and show that the MDM2 SNP309 determines the functional outcome of patients after stroke.
引用
- Rodríguez C, Ramos-Araque ME, Domínguez-Martínez M, et al. Single-Nucleotide Polymorphism 309T>G in the MDM2 Promoter Determines Functional Outcome After Stroke. Stroke. 2018. PMID: 30355102. doi:10.1161/STROKEAHA.118.022529
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。